PAR 823 (Tramadol hydrochloride extended release 300 mg)
Pill imprint PAR 823 has been identified as Tramadol hydrochloride extended release 300 mg.
Tramadol is used in the treatment of back pain; chronic pain; anxiety; depression; pain (and more), and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Tramadol 300 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- PAR 823
- Strength:
- 300 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Narcotic analgesics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 4 - Some potential for abuse
- Manufacturer:
- Par Pharmaceutical Companies, Inc.
- National Drug Code (NDC):
- 49884-0823
- Inactive Ingredients:
- silicon dioxide colloidal
dibutyl sebacate
magnesium stearate
polyvinyl alcohol
povidone k90
shellac
ferric oxide black
isopropyl alcohol
propylene glycol
ammonia
More about tramadol
Consumer resources
- Tramadol
- Tramadol extended-release capsules
- Tramadol extended-release tablets
- Tramadol orally disintegrating tablets
- Tramadol (Advanced Reading)
- Other brands: Ultram, ConZip, Ultram ER, Rybix ODT, More (1) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
